TL;DR

Multiple cetirizine allergy medications are under recall across the US due to contamination risks. Consumers are advised to check their medications and consult healthcare providers. The recall impacts several brands and is ongoing.

Several brands of cetirizine allergy medication are being voluntarily recalled across the United States due to potential contamination, according to the Food and Drug Administration (FDA). The recall affects products distributed by multiple manufacturers and is part of a broader effort to ensure consumer safety amid reports of possible impurities.

The FDA announced the recall on March 25, 2026, after discovering traces of foreign particles in certain batches of cetirizine hydrochloride tablets and liquids. The affected products include over-the-counter allergy medications sold under various brand names, with specific lot numbers and expiration dates listed on the FDA website.

Manufacturers involved include major pharmaceutical companies, which initiated the recall voluntarily after internal testing revealed contamination. The FDA has advised consumers to check their medication labels carefully and to cease use of any recalled products. No injuries or adverse health effects have been officially reported at this time, but health officials warn of potential risks from ingesting contaminated medication.

Pharmacies and retailers have been instructed to remove the affected products from shelves, and consumers are urged to return them to the point of purchase or dispose of them safely. The FDA and manufacturers are investigating the source of the contamination, but details remain undisclosed as of now.

At a glance
breakingWhen: announced March 2026, ongoing
The developmentA nationwide recall of certain cetirizine allergy medications has been announced due to contamination concerns, affecting multiple brands and prompting health authorities to issue alerts.

Potential Health Risks and Consumer Impact

This recall highlights the importance of medication safety and the potential health risks associated with contaminated pharmaceuticals. While no adverse effects have been confirmed, consumers who have used the affected cetirizine products are advised to consult healthcare providers. The recall may also impact supply chains and access to allergy medications during peak allergy season, raising concerns for allergy sufferers nationwide.

Amazon

cetirizine allergy medication alternative

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Background on Cetirizine and Recent Recalls

Cetirizine is a widely used antihistamine for allergy relief, available over the counter and by prescription. Past recalls of allergy medications have typically involved manufacturing issues or contamination, but this is among the most extensive in recent years, affecting multiple brands simultaneously. The FDA has increased surveillance of OTC medications following previous incidents of contamination and quality control lapses.

This recall follows similar actions in 2024 when certain antihistamines were withdrawn due to contamination concerns, underscoring ongoing challenges in pharmaceutical manufacturing and quality assurance.

“We are actively investigating the contamination issue and are working with manufacturers to ensure all affected products are removed from the market.”

— FDA spokesperson

Details of the Contamination and Affected Products Still Unclear

It is not yet clear what specific contaminants have been found in the affected cetirizine products or the exact source of contamination. The full list of affected lots and brands remains incomplete, and investigations are ongoing to determine the scope and cause of the issue. No official reports of health incidents have been confirmed, but authorities continue to monitor the situation.

Next Steps for Consumers and Regulators

Regulatory agencies are expected to release updated lists of affected products and provide further safety guidance. Manufacturers will continue their investigations, and additional recalls may be announced if more contaminated batches are identified. Consumers should stay informed through official channels, check their medications carefully, and consult healthcare providers if needed. The FDA is also expected to review manufacturing practices to prevent future incidents.

Key Questions

Which cetirizine products are affected by the recall?

The recall includes specific lots of cetirizine tablets and liquids from multiple brands, with details available on the FDA website. Consumers should check their medication labels for lot numbers and expiration dates.

What are the potential health risks from contaminated cetirizine?

While no adverse effects have been officially reported, ingestion of contaminated medication could pose health risks depending on the nature of the contaminants. Consumers are advised to consult healthcare providers if they experience unusual symptoms.

Should I stop using my cetirizine medication immediately?

If your medication is part of the affected lots, the FDA recommends discontinuing use and returning or disposing of the product. Consult your healthcare provider for alternative allergy treatments if necessary.

How can I identify if my medication is recalled?

Check the lot number and expiration date on your medication packaging against the information provided on the FDA website or contact your pharmacy for assistance.

Will there be a replacement or new batch of cetirizine available?

Manufacturers are working to resolve the contamination issue and produce safe, uncontaminated batches. Updates on availability will be communicated through official channels.

Source: google-trends

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Comprehensive review affirms that COVID mRNA vaccines are safe, effective

A new comprehensive review affirms that COVID-19 mRNA vaccines are safe and effective, supporting their continued use amid ongoing pandemic concerns.

Stiko-empfehlung Corona-impfung

Germany’s STIKO issues new vaccination recommendations for COVID-19, focusing on vulnerable groups. The update aims to improve immunity amidst evolving virus variants.

Cases of ‘explosive diarrhea’ infections spread in U.S., with major Midwest outbreak

Over 200 cases of cyclospora infections causing explosive diarrhea have been reported across the U.S., with a significant outbreak in the Midwest. Details are still emerging.

Ballarat Regional Integrated Cancer Centre Surges In Global Coverage

Ballarat Regional Integrated Cancer Centre sees a surge in international coverage, with 24 mentions in recent global media analysis, highlighting its growing prominence.